Senior Director Caregiver Marketing

Do you want to join a team where the mission is meaningful, the challenges are complex, and you can directly see the results of your hard work? Lundbeck is a global biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases.

Lundbeck employees are inspired and driven by our purpose to advance brain health and transform lives. Join us on our journey of growth!

Bexicaserin is an investigational therapy that has not been approved by the Food and Drug Administration (FDA) for use in Developmental and Epileptic Encephalopathies (DEEs) or any indication. Additional research and information are needed to fully evaluate its safety and efficacy.

The Senior Director, Caregiver Marketing will play a critical leadership role in preparing Lundbeck's Rare Epilepsy portfolio for launch, with an initial focus on bexicaserin.

Caregivers are central to the DEE treatment journey, often serving as the primary information seeker, care navigator and advocate for their loved one. This leader will develop a deep understanding of caregiver needs and behaviors and translate those insights into strategies that increase awareness, help caregivers recognize unmet needs and motivate informed conversations with healthcare providers.

The Senior Director will also lead the Rare Epilepsy commercial strategy for AI-mediated information discovery, including the growing role of large language models (LLMs) in how caregivers find and understand health information. Success will require strong cross-functional leadership across Analytics and Customer Experience, Medical Affairs, Corporate Communications, Global, Patient Advocacy, Patient Services and other partners to create a connected caregiver experience and coherent content and context strategy.

• Lead the U.S. caregiver marketing strategy, with particular accountability for building awareness and driving activation in preparation for and following launch.
• Develop a deep understanding of the DEE caregiver journey, including unmet needs, treatment goals, barriers, information needs and the role caregivers play in treatment decisions and care navigation.
• Translate caregiver insights into behavioral objectives, disease education, positioning, messaging and integrated marketing strategies.
• Develop strategies that help caregivers recognize unmet needs, understand evolving treatment possibilities and engage healthcare teams in informed conversations about treatment goals and options.
• Establish measures of caregiver awareness, engagement and activation and use performance insights to evolve strategy and investment.

• Partner with the Vice President of Rare Epilepsy Marketing and Senior Director, HCP & Payer Marketing to shape the integrated U.S. brand strategy, positioning and launch plan.
• Partner with Patient Advocacy to ensure strategy reflects an authentic understanding of the rare epilepsy community while maintaining appropriate functional boundaries.
• Partner closely with Patient Services to create a connected caregiver experience from awareness and activation through treatment access, onboarding and ongoing support, using caregiver insights to inform both marketing and service design.
• Serve as the strategic marketing lead for caregiver engagement, partnering closely with ACE to translate customer strategy into integrated omnichannel execution across digital, media, CRM and emerging channels.
• Create alignment across Medical Affairs, Corporate Communications, Global, Market Access, ACE and other partners around critical caregiver and launch priorities.

• Lead the Rare Epilepsy commercial strategy for how LLMs and other AI-enabled platforms are changing the way caregivers discover, understand and evaluate information about DEEs and treatment options.
• Serve as the commercial integrator across Corporate Communications, Medical Affairs, Global, ACE, Patient Advocacy, HCP & Payer Marketing and other partners to establish shared priorities for AI-mediated information discovery.
• Develop, with cross-functional partners, an integrated content and context strategy designed for both human and AI-mediated discovery.
• Partner with ACE to understand how DEEs, treatment options and, when appropriate, bexicaserin are discovered and represented across…